The expression of platelet-derived endothelial cell growth factor in human bladder cancer

Cancer Letters

Volumn 130, Issue 1-2, 1998, Pages 35-41

  Sawase, Kenji ^a   Nomata, Koichiro ^a   Kanetake, Hiroshi ^a   Saito, Yutaka ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Bladder cancer; Immunohistochemistry; Platelet derived endothelial cell growth factor

Indexed keywords

ANGIOGENIC FACTOR; EPIRUBICIN; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER STAGING; CLINICAL ARTICLE; CORRELATION FUNCTION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; THYMIDINE PHOSPHORYLASE; URINARY BLADDER NEOPLASMS;

EID: 0032516709     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00097-4     Document Type: Article

References (18)

1. Alvaro S.S., Guido D., Carlos C.C., Zuo F.Z., Joel S., William R.F., Harry W.H., Victor E.R. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma. J. Natl. Cancer Inst. 85:1993;53-59.
2. Logothetis C.J., Xu H.J., Ro J.Y., Hu S.X., Sahin A., Ordonez N., Benedict W.F. Alternated expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J. Natl. Cancer Inst. 84:1992;1256-1261.
3. Coombs L.M., Pigott D.A., Sweeney E., Proctor A.J., Eydmann M.E., Parkinson C., Knowles M.A. Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder. Br. J. Cancer. 63:1991;601-608.
4. Bernard H.B., Richard J.C., Noel W., Susan G., Su C.C., Donald G.S., Peter W.N. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J. Natl. Cancer Inst. 87:1995;1603-1612.
5. Philp E.A., Stephenson T.J., Reed M.W.R. Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder. Br. J. Urol. 77:1996;352-357.
6. Miyazono K., Okabe T., Urabe A., Takaku F., Heldin C.H. Purification and properties of an endothelial cell growth factor from human platelets. J. Biol. Chem. 262:1986;4098-4103.
7. Ishikawa F., Miyazono K., Hellman U., Drexler H., Wernstedt C., Hagiwara K., Usuki K., Takaku F., Risau W., Heldin C.H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature. 338:1989;557-562.
8. Miyadera K., Sumizawa T., Haraguchi M., Hiroki Y., Konstanty W., Yamada Y., Akiyama S. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res. 55:1995;1687-1690.
9. Fox S.B., Moghaddam A., Westwood M., Turley H., Bicknell R., Gatter K.C., Harris A.L. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues; an immunohistochemical study. J. Pathol. 175:1995;183-190.
10. Takebayashi Y., Yamada K., Sumizawa T., Furukawa T., Kinoshita F., Aoki D., Okumura H., Yamada Y., Akiyama S., Aikou T. The activity and expression of thymidine phosphorylase in human solid tumors. Eur. J. Cancer. 32:1996;1227-1232.
11. Fox S.B., Westwood M., Moghaddam A., Comley M., Turley H., Whitehouse R.M., Bicknell R., Gatter K.C., Harris A.L. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer normal and endothelium. Br. J. Cancer. 73:1996;275-280.
12. Nishida M., Hino A., Mori K., Mastumoto T., Yoshikubo T., Ishituka H. Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol. Pharm. Bull. 19:1996;1407-1411.
13. Kubota Y., Miura T., Moriyama M., Noguchi S., Mastuzaki J., Takebayashi S., Hosaka M. Thymidine phosphorylase activity in human bladder cancer: difference between superficial and invasive cancer. Clin. Cancer Res. 3:1997;973-976.
14. Mizutani Y., Okada Y., Yoshida O. Expression of platelet-derived endothelial cell growth factor in bladder carcinoma. Cancer. 79:1997;1190-1194.
15. O'Brien T.S., Fox S.B., Dickinson A.J., Turley H., Westwood M., Moghaddam A., Whitehouse R.M., Gatter K.C., Bicknell R., Harris A.L. Expression of angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancer. Cancer Res. 56:1996;4799-4804.
16. Heney N.M., Ahmed S., Flanagan M.J., Frable W., Corder M.P., Hafermann M.D., Hawkins I.R. Superficial bladder cancer: progression and recurrence. J. Urol. 130:1983;1083-1086.
17. Pansadoro V., Emiliozzi P., Defidio L., Donadio D., Florio A., Maurelli S., Lauretti S., Sternberg C.N. Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results. J. Urol. 154:1995;2054-2058.
18. O'Brien T., Cranston D., Fuggle S., Bicknell R., Harris A.L. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res. 55:1995;510-513.